NGVTIngevity Corporation
$69.86+24% 1Y
$69.86
$46.2052 weeks$77.87
NGVT in its own filings
Nothing in NGVT's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
194
Events found in the filings · across 658 filings · the record starts in 2015
- Hard flags
- none
Hard flags
- Most recent filing
- Jul 30, 2026
Most recent filing · Form 10-Q
- Record starts
- Nov 2, 2015
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 4, 2026
- Material impairmenthistorical
- 2016-11-03
- SEC comment-letter activity22 occurrences
- 2025-03-21
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jul 29, 2026North Charleston, SC 29405 USA.Earnings release · press release
- Jun 24, 2026On June 22, 2026, Ryan Cotterman, age 44, was appointed as Vice President, Chief Accounting Officer and principal accounting officer of Ingevity Corporation (the “Company”)Director or officer change · Form 8-K
- May 6, 2026North Charleston, SC 29405 USA.Earnings release · press release
- May 4, 2026On April 29, 2026, Ingevity Corporation (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”)Director or officer change · Form 8-K
- Apr 15, 2026North Charleston, SC 29405 USA.Regulation FD disclosure · press release
- Mar 30, 2026On March 26, 2026 (the “Closing Date”), Ingevity Corporation (the “Company”), Ingevity Holdings SRL (“Holdings”), Ingevity UK Ltd (the “UK Borrower”), the other loan parties party thereto, the lenders party thereto, the issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the …Material agreement entered · Form 8-K
- Feb 25, 2026North Charleston, SC 29405 USA.Earnings release · press release
- Feb 23, 2026On February 17, 2026, Jean S. Blackwell informed the Nominating & Governance Committee of the Board of Directors (the “Board”) of Ingevity Corporation (the “Company”) that she will not stand for election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”)Director or officer change · Form 8-K
- Jan 5, 2026Amendment to Asset Purchase Agreement In connection with the Closing, on January 1, 2026, the Parties entered into the Amendment, which, among other things, modified the scope of assets being transferred pursuant to the Original Purchase Agreement by excluding non-lignin dispersant products sold to existing customers …Material agreement entered · Form 8-K
- Dec 8, 2025Chief Financial Officer Transition On December 8, 2025, Ingevity Corporation (“Ingevity” or the “Company”) announced that Mary Dean Hall, Executive Vice President and Chief Financial Officer (“CFO”) of the Company, will transition from her current role, effective May 1, 2026.Director or officer change · Form 8-K
- Dec 8, 2025Charleston, S.C. 29405 USA.Regulation FD disclosure · press release
- Dec 1, 2025Recast Condensed Consolidated Statement of Operations, Historical Segment Information and certain Non-GAAP Financial Measures Excluding the Industrial Specialties product line and CTO Refinery (Discontinued Operations) (Unaudited)Regulation FD disclosure · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Specialty Chemicals
Ranks #5 of 33 by RyuScore